View other perspectives:

MACRO INTELLIGENCE MEMO • MARCH 2026 • CEO & BOARD STRATEGY EDITION

Cuba's AI Paradox: Biotech Innovation, State Enterprise Transformation, and the Quest to Build AI Competitiveness by 2030

How Cuban business leaders must navigate a $107B economy transitioning from imported dependence to indigenous innovation under US embargo constraints

Economic Context: The Embargo Economy and Contraction Cycle

Cuba's economy is defined by paradox: a sophisticated population with high literacy (99.8%), significant biotech innovation capacity, yet persistent macroeconomic contraction. The nominal GDP stands at approximately $107 billion (estimated 2025), with the government projecting just 1% growth for 2026—though the United Nations Economic Commission for Latin America and the Caribbean (ECLAC) forecasts a –1.5% contraction.

Per capita income averages $9,500 annually across a population of 11.2 million, but this figure masks severe underemployment and currency distortions. The average monthly salary in Cuban Pesos (CUP) is 6,649–6,830 CUP, equivalent to roughly $55–57 USD at the official exchange rate. However, skilled professionals in high-demand sectors earn $166–250 USD/month, and top engineers or researchers in state biotech firms can reach $300–400 USD/month—still a fraction of regional comparators.

Two consecutive years of negative GDP growth (2023–2024) have strained state enterprises, reduced foreign exchange reserves, and accelerated emigration. The Cuban government, facing the worst economic crisis since the 1990s Soviet collapse, has launched an emergency program to "correct distortions and boost the economy" (2025), prioritizing exports and private sector expansion—a significant shift from decades of state monopoly.

The US embargo—in place since 1962—remains the structural constraint. Restrictions on technology imports, sanctions on financial transactions, and prohibitions on access to US software and cloud infrastructure force Cuban enterprises to build domestic alternatives or rely on indirect sourcing through third countries.

CEO Implication: Cuba's contraction creates urgency. CEOs of state enterprises must accelerate AI adoption not as an efficiency play but as a survival mechanism for competitiveness. Private enterprise growth creates immediate opportunities for Cuban entrepreneurs willing to operate at the edge of regulatory ambiguity.

Cuba's National AI Strategy: Six Axes and State Control

In 2023, the Cuban government formalized its National AI Strategy with six core axes, representing the most coherent technology plan announced in decades:

  • Ethics and Regulatory Framework: Establishing principles for responsible AI deployment across state institutions
  • Human Capital Development: Training a new generation of AI engineers, data scientists, and researchers—prioritizing university partnerships
  • AI Applications: Deploying AI in priority sectors (healthcare, agriculture, tourism, biotech) with government funding
  • Public Administration Digitization: Using AI to modernize government services, bureaucratic efficiency, and citizen engagement
  • Science and Innovation Infrastructure: Building domestic AI research capabilities and reducing dependency on foreign innovation
  • Social Communication: Ensuring AI benefits reach all citizens and addressing digital inequality

The government has committed significant state resources to AI development through research institutes (such as the Center for Artificial Intelligence Development), university programs at top institutions (University of Havana, University of Informatic Sciences), and partnerships with state enterprises. The goal is to position Cuba as a "knowledge and high-tech export powerhouse" by 2030—a stated priority in government economic plans.

Internet penetration is rising. Mobile adoption has surged from near-zero in 2017 to approximately 70% of the population by 2025, and 4G coverage now reaches major urban areas. Domestic bandwidth remains limited and expensive, but this constraint is driving investment in edge computing and locally-deployed AI solutions rather than cloud-dependent architectures.

The legalization of Micro, Small, and Medium Enterprises (MSMEs) in 2021 created space for private technology entrepreneurship. While most AI investment remains concentrated in state enterprises, a small but growing ecosystem of private tech startups has emerged, particularly in software development, digital services, and tourism technology.

CEO Implication: Government strategy creates investment signals and funding availability. CEOs in state enterprises should align AI initiatives with the six national axes to access government resources. Private sector CEOs should exploit gaps in state enterprise automation—customer service, marketing analytics, tourism optimization—where rapid, market-driven AI deployment can differentiate offerings.

The BioCubaFarma Advantage: AI-Augmented Pharma Innovation

Cuba's most defensible economic advantage is biotech. BioCubaFarma, the state-owned biopharmaceutical conglomerate, is the world's most productive biotech company per capita and has generated approximately $2 billion in historical export revenue. The portfolio includes:

  • Interferon Alpha-2B: A Spanish-Cuban joint venture producing antiviral treatments
  • Hepatitis B and Meningitis Vaccines: Domestically developed vaccines sold across Latin America and Africa
  • Monoclonal Antibodies: Custom immunotherapies and diagnostic tools
  • Cancer Therapeutics: Research-stage drugs in preclinical development

AI applications in biotech are immediately productive: molecular docking simulations, drug candidate screening, clinical trial optimization, and manufacturing quality control. Cuba's high scientific workforce (0.5% of GDP invested in R&D—the highest rate in Latin America) combined with embedded biotech expertise creates a foundation for AI-accelerated pharmaceutical development.

The embargo paradoxically strengthens BioCubaFarma's position. Sanctions prevent Cuban patients from accessing most Western pharmaceuticals, creating captive demand for domestic innovation. Concurrently, embargo restrictions on US biotech exports make Cuban-developed generics and alternative therapies attractive across Latin America, Africa, and select Asian markets. BioCubaFarma already has distribution agreements in 50+ countries.

AI deployment in BioCubaFarma's pipeline offers immediate ROI: accelerating drug discovery timelines, improving manufacturing yields, and enabling personalized medicine applications. A 2025 government initiative directed biotech companies to integrate AI into R&D, providing research funding for molecular modeling, genomic analysis, and AI-driven clinical decision support.

CEO Implication: If you lead a BioCubaFarma business unit, AI is not optional—it is the mechanism for competing globally while avoiding technology embargoes. Invest heavily in AI research partnerships with university labs (which face fewer sanctions) and capture government biotech AI funding before competitors do. The next wave of Cuban pharmaceutical exports will be determined by AI-augmented development speed.

Technology Ecosystem: Creativity Under Embargo

Cuba's technology sector operates in a unique environment: high technical literacy, constrained capital and imports, but fierce ingenuity. Key characteristics:

  • Software Development Talent: Cuba produces world-class software engineers. Remote work for international companies (via third-country intermediaries) generates significant foreign exchange for skilled professionals.
  • Tourism Technology: Airbnb-equivalent platforms (Casagranhosted), tourism booking engines, and hospitality management systems have emerged to serve the growing tourism sector (pre-COVID: 4 million visitors annually).
  • Financial Technology Innovation: Digital payment systems (like TransferMĂłvil) have evolved to navigate the dual currency legacy (Cuban Pesos and the convertible CUC) and serve the unbanked population.
  • Agricultural Technology: Given Cuba's heavy reliance on agriculture, startups are developing precision farming solutions, pest detection using computer vision, and crop yield optimization AI—addressing urgent food security concerns.
  • Healthcare IT: A robust state health IT ecosystem supports universal healthcare delivery. AI applications in patient triage, diagnostic assistance, and epidemic tracking are already deployed across regional hospitals.

The startup ecosystem, while nascent, is growing. Incubators like Havana Tech and university-affiliated programs provide mentoring and limited seed funding. Most private tech ventures are co-founded by returning diaspora members with capital access and international networks. The government, recognizing the export potential, has loosened restrictions on tech entrepreneurs—some private software companies now operate with relative autonomy.

Internet infrastructure remains the bottleneck. Domestic bandwidth is limited; international connectivity routes through government-controlled channels; and cloud computing costs are elevated due to sanctions-imposed tariffs. This constraint drives adoption of edge computing, offline-first architectures, and locally-deployed AI models—technical innovations that have export value in other bandwidth-constrained markets (Sub-Saharan Africa, Southeast Asia).

CEO Implication: The embargo is a competitive differentiator, not just a constraint. Cuban tech solutions built to work offline, with limited bandwidth, and without reliance on US cloud infrastructure are immediately exportable to developing markets. If you're a private tech CEO, build for constraint—the resulting product has global addressable market in the billions.

Three Bear Scenarios: State Enterprise AI Failures

Bear Scenario 1: Havana Electrical Company's Grid Modernization Stall

Company: Unión Eléctrica de Cuba (UNE) — Cuba's state-owned electricity monopoly.

The Scenario: In 2024, UNE announced a $60 million AI initiative to modernize the national grid: smart meters, predictive maintenance for aging infrastructure, and demand forecasting. Initial pilots in Havana showed 10–12% efficiency gains and reduced blackouts by 8%. However, scaling encountered multiple obstacles: software vendors requiring US-sanctioned technology, international cloud platforms unavailable due to embargo, and a shortage of data scientists trained on modern AI frameworks. By 2027, the project had stalled. UNE continues experiencing 20+ blackouts monthly across the island. The expensive hardware sits partially deployed. The AI initiative becomes a cautionary tale of state enterprise ambition exceeding technical execution capacity.

Root Cause: State enterprises lack agility to adapt when foreign vendors are unavailable. AI projects that depend on international partnerships face unresolvable delays. Domestic talent is insufficient to compensate for technology gaps.

Bear Scenario 2: Havana Port Authority's Cargo Optimization Collapse

Company: Autoridad Portuaria de La Habana — Cuba's primary maritime trade hub.

The Scenario: The Port Authority invested $25 million (in precious foreign currency) in AI systems for cargo optimization, vessel scheduling, and dockside resource allocation. The systems were trained on 20 years of historical port data. Performance initially exceeded expectations: 15% throughput improvement, reduced waiting times, and optimized crane scheduling. However, by 2026, fundamental assumptions shifted: new shipping routes bypassed Havana due to US policy changes, cargo composition changed dramatically due to agricultural disruptions, and vessel size increased (requiring retraining of all models). The AI system, frozen in 2024 assumptions, became a liability—making predictions increasingly divorced from reality. The Port Authority reverted to human schedulers. The expensive AI infrastructure was repurposed for unrelated administrative tasks.

Root Cause: State enterprises cannot retrain AI systems rapidly when underlying conditions shift. The embargo creates a unique volatility: policy changes can instantly alter trade flows. Static AI models fail under these conditions.

Bear Scenario 3: The Brain Drain Collapse

Company: Composite scenario representing dozens of Cuban tech enterprises.

The Scenario: From 2024–2026, Cuba experienced one of the largest emigration waves since the 1990s. Over 300,000 Cubans left the island in 2024 alone, including a disproportionate share of the tech workforce. AI and data science teams at state enterprises, biotech companies, and tech startups lost 40–60% of personnel. A major telecom company invested heavily in training 50 data scientists; within 18 months, 28 had emigrated. AI projects dependent on institutional knowledge ground to a halt. Recruitment efforts failed to compensate for the talent exodus. By 2026, many ambitious AI initiatives had been scaled back or abandoned. The remaining workforce was demoralized, knowing that emigration represented a superior financial outcome.

Root Cause: AI ambitions cannot be sustained when the talent base is destabilized by superior opportunities abroad. Cuba's tech workers can earn 3–5x higher salaries in the US or other developed economies. No amount of government incentive can fully offset this differential.

Three Bull Scenarios: Biotech and Services Dominance

Bull Scenario 1: BioCubaFarma's AI-Driven Vaccine Pipeline

Company: BioCubaFarma Research Division — State biotech conglomerate.

The Scenario: Between 2025–2028, BioCubaFarma invested $80 million in AI-accelerated drug discovery, funded by government priority allocation. A consortium of Cuban universities (Havana, UNAM) contributed molecular modeling expertise. The result: accelerated development of three novel cancer immunotherapies and a next-generation dengue vaccine. The dengue vaccine, trained on 30 years of Cuban epidemiological data and optimized via AI-driven clinical trial design, achieved 95% efficacy in phase 2 trials—superior to existing competitors. By 2029, BioCubaFarma signed licensing agreements with governments in Brazil, Mexico, and 15 African nations for the dengue vaccine alone, generating $500M+ in committed revenue over 10 years. The cancer therapies entered global phase 3 trials. BioCubaFarma had transformed from a sanctions-constrained producer into a global innovation leader.

Root Cause: Biotech is exportable innovation. AI-accelerated drug discovery has global market pull regardless of embargo constraints. Cuba's biotech talent and institutional capacity create a defensible moat.

Bull Scenario 2: Havana Tech's Global Fintech Export Platform

Company: Havana Innovations (composite of emerging private tech firms).

The Scenario: A group of Cuban software engineers, funded by returning diaspora capital ($15 million), founded a fintech company optimized for emerging markets with poor internet connectivity and dual-currency economies. They built AI-driven fraud detection, offline transaction processing, and machine learning models for credit scoring in underbanked populations. The product was first deployed in Cuba to serve the unbanked and underbanked; then expanded to Haiti, Dominican Republic, and Jamaica; then to Sub-Saharan Africa. By 2028, the platform processed $2 billion in annual transactions across 12 countries, with 60% margins on software licensing. The company achieved unicorn valuation and expanded AI capabilities to include predictive analytics for remittance flows and agricultural commodity pricing. The embargo, far from constraining this venture, accelerated product-market fit by forcing innovation under real constraints that resonated globally.

Root Cause: Private tech ventures unburdened by state enterprise bureaucracy can move rapidly. Building for constraint creates exportable innovation. Global venture capital recognizes the opportunity and funds diaspora-led Cuba tech ventures.

Bull Scenario 3: Tourism AI Personalization Dominance

Company: Cubafor (composite of tourism tech ventures).

The Scenario: Cuba's tourism sector, recovering post-pandemic to 3.5 million annual visitors by 2028, became the target for AI-driven personalization platforms. Cuban tourism tech companies deployed machine learning for: personalized resort recommendations, dynamic pricing for accommodations, AI-powered tour guide matching (assigning guides to tourists based on language, interests, and compatibility algorithms), and predictive maintenance for hospitality infrastructure. The platforms processed real-time behavioral data (unprecedented in Cuban hospitality). By 2028, AI-driven personalization increased average tourist spending by 22% and reduced no-show rates by 18% across major resort chains. A major tourism tech platform was acquired by a regional hospitality group for $200M, generating outsized returns for founders. Tourism, Cuba's largest foreign exchange generator, became a testbed for AI innovation with strong economic returns.

Root Cause: Tourism is a natural AI application domain. Personalization has immediate revenue impact. Cuba's tourism boom creates a large, captive customer base for tech innovation.

2030 CEO Roadmap: Six Strategic Imperatives

1. Align with National AI Strategy's Six Axes (2026–2027)

The Cuban government has published its AI strategy. Position your enterprise to capture government funding, research partnerships, and regulatory alignment. If you lead a state enterprise, ensure your AI roadmap explicitly addresses one or more of the six axes. If you lead a private enterprise, identify where your innovations support government priorities (healthcare, agriculture, public administration) to secure partnerships and legitimacy.

Action: Audit your AI initiatives against the six axes. Reallocate resources to align with government emphasis. Apply for government R&D funding and university partnerships.

2. Biotech Leaders: Prioritize AI-Accelerated Drug Development (2026–2028)

If you lead a biotech enterprise, AI is the mechanism for competing globally without violating embargoes. Focus on: molecular modeling, genomic analysis, clinical trial optimization, and manufacturing process AI. Invest in university partnerships to access research talent. Pursue government biotech AI funding aggressively.

Action: Allocate 15–20% of R&D budgets to AI capability building. Partner with University of Havana's computational biology program. Pursue government biotech R&D grants.

3. Build for Constraint, Export Globally (2026–2029)

Whether you lead a tech startup or state enterprise, design AI solutions optimized for:

  • Limited bandwidth environments (offline-first, edge computing)
  • Dual or unstable currency economies (local pricing models)
  • Incomplete digital infrastructure (works with partial data, poor connectivity)

These solutions are immediately exportable to developing markets across Africa, Asia, and Latin America. The embargo is an inadvertent research lab for constraint-driven innovation.

4. Talent Retention Through Equity and Mission (2026–2030)

The brain drain is accelerating. Compensation alone cannot compete with international offers. However, equity ownership, meaningful work on nation-building projects, and flexible remote arrangements (where politically feasible) can retain some top talent. University partnerships can create pipelines of freshly-trained engineers before emigration temptation sets in.

Action: Offer meaningful equity stakes in AI projects. Frame work as addressing critical national challenges (healthcare, agriculture, energy). Provide remote work flexibility for high-performers.

5. Private Sector Expansion: Exploit State Enterprise Automation Gaps (2026–2029)

State enterprises, hampered by bureaucracy, move slowly on AI adoption. Private entrepreneurs can capture opportunities in customer service automation, marketing analytics, supply chain optimization, and tourism technology. The regulatory environment is increasingly permissive for tech MSMEs. Diaspora capital access and international networks provide competitive advantage.

Action: If you're a private tech founder, identify verticals where state enterprises are underinvesting. Secure diaspora funding and international partnerships (where not legally restricted). Move quickly—first-movers capture market share before state competition emerges.

6. Prepare for Multiple Embargo Scenarios (Ongoing)

Technology strategy should be viable under three futures: (a) embargo persists indefinitely, (b) embargo partially eases (allowing select technology access), (c) embargo fully lifts (opening US market access and Western cloud infrastructure). Build AI infrastructure flexible enough to operate under any scenario. Avoid irreversible bets on embargo continuation or termination.

Action: Design AI systems that can operate on domestic infrastructure AND integrate with international cloud platforms if embargo eases. Maintain technology partnerships with non-US vendors to preserve optionality.

References & Data Sources

  1. ECLAC Economic Survey of Latin America 2025 – Cuba Country Profile
    https://www.cepal.org/en/publications
  2. World Bank World Development Indicators – Cuba
    https://data.worldbank.org/country/CUB
  3. BioCubaFarma Official Website – Pharmaceutical Portfolio and Exports
    https://www.biocuba.cu/
  4. UN News – Cuba's National AI Strategy Implementation 2025
    https://news.un.org/en/news/search?query=cuba%20AI%20strategy
  5. Trading Economics – Cuba Economic Indicators
    https://tradingeconomics.com/cuba/gdp
  6. International Labour Organization – Caribbean Youth Employment 2025
    https://www.ilo.org/caribbean
  7. Miami Herald – Cuba Emigration Wave 2024-2025
    https://www.miamiherald.com/
  8. Statista – Cuba Internet Penetration and Mobile Usage 2025
    https://www.statista.com/outlook/dmo/digital-markets/cuba